United States Patent and Trademark Office OG Notices: 02 November 2004

                                 Dedications

   5,863,559  -  Anthony John Phillips, Ware, Great Britain; Ian
Keith Winterborn, Mississauga, Canada; John Malcolm Padfield, Uxbridge,
Great Britain. ORAL DOSAGE FORM FOR TREATING MIGRAINE. Patent dated
January 26, 1999. Disclaimer and dedication filed August 16, 2004, by
the assignee, Glaxo Group, Ltd., d/b/a GlaxoSmithKline.

   Hereby dedicates to the Public, claims 1, 2, 3, 4, 5, and 6 for
the entire term of said patent.


   6,368,627  -  Anthony John Phillips, Ware, (GB); Ian Keith
Winterborn, Mississauga, (CA); John Malcolm Padfield, Uxbridge, (GB).
COMPOSITIONS. Patent dated April 9, 2002. Disclaimer and dedication
filed August 16, 2004, by the assignee, Glaxo Group, Ltd., d/b/a
GlaxoSmithKline.

   Hereby dedicates to the Public claim 1, which is the sole claim
of the patent, for the entire term of said patent.


   6,020,001  -  Anthony John Phillips, Ware, United Kingdom; Ian
Keith Winterborn, North Mississauga, Canada; John Malcolm Padfield,
Middlesex, United Kingdom. ORAL DOSAGE FORM FOR TREATING MIGRAINE.
Patent dated February 1, 2000. Disclaimer and dedication filed August
16, 2004, by the assignee, Glaxo Group, Ltd., d/b/a GlaxoSmithKline.

   Hereby dedicates to the Public, claims 1, 2, 3, 4, 5, 6 and 7
for the entire term of said patent.